BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty has maintained a Market Perform rating on Ingevity (NGVT) and increased the price target from $50 to $55.
May 08, 2024 | 3:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital has maintained its Market Perform rating on Ingevity and raised the price target from $50 to $55.
The increase in price target by BMO Capital suggests a positive outlook on Ingevity's stock, potentially leading to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100